BIOCON'S PERTUZUMAB BECOMES FIRST BIOSIMILAR TO SECURE EMA CHMP APPROVAL RECOMMENDATION UNDER NEW TAILORED CLINICAL APPROACH

Reuters · 1d ago

Please log in to view news